UK markets closed

RedHill Biopharma Ltd. (RDHL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4498-0.0009 (-0.20%)
At close: 04:00PM EDT
0.4579 +0.01 (+1.80%)
After hours: 05:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
23,916
23,916
-71,669
-97,744
-76,173
Depreciation & amortisation
1,990
1,990
8,154
18,149
8,745
Stock-based compensation
1,647
1,647
5,675
10,212
4,202
Change in working capital
-15,619
-15,619
8,008
-1,153
8,420
Accounts receivable
31,930
31,930
-2,845
-3,021
-27,439
Inventory
2,387
2,387
3,801
-8,285
-4,644
Accounts payable
-952
-952
-7,434
111
7,369
Other working capital
-35,831
-35,831
-29,383
-65,162
-102,353
Other non-cash items
-543
-543
33,151
5,366
6,032
Net cash provided by operating activities
-35,820
-35,820
-29,185
-65,047
-48,579
Cash flows from investing activities
Investments in property, plant and equipment
-11
-11
-198
-115
-53,774
Purchases of investments
-
-
-
-8,500
0
Sales/maturities of investments
15
15
8,500
475
18,125
Net cash used for investing activities
4
4
8,302
-8,140
-35,649
Cash flows from financing activities
Debt repayment
-1,175
-1,175
-1,475
-1,683
-1,610
Common stock issued
13,959
13,959
23,806
78,536
23,867
Other financing activities
8,655
8,655
-10,878
-7,397
-16,000
Net cash used provided by (used for) financing activities
21,439
21,439
11,453
73,462
84,370
Net change in cash
-14,377
-14,377
-9,430
275
142
Cash at beginning of period
19,968
19,968
29,474
29,295
29,023
Cash at end of period
5,569
5,569
19,968
29,474
29,295
Free cash flow
Operating cash flow
-35,820
-35,820
-29,185
-65,047
-48,579
Capital expenditure
-11
-11
-198
-115
-53,774
Free cash flow
-35,831
-35,831
-29,383
-65,162
-102,353